1Gibson CM,Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J]. Circulation, 2000,101(2) : 125-130.
2Omland T,de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes[J]. Am J Cardiol, 2002, 89(4) :463-465.
4Mair J, Friendl W, Thomas S, et al. Natriuretie peptides in assessment of left -ventrieular dysfunetion[J]. Seand J Clin Lab Invest Suppl,1999,230(2) :132-142.
5Berger R, Huelsman M, Streeker K, et al. B-type natriuretie peptide predicts sudden death in patients with chronic heart failure[J]. Circulation, 2002,105(20) : 2392-2397.
5Feil R, Lohmann SM, de Jonge H, et al. Cyclic GMP-dependent protein kinases and the cardiovascular system: insight from genetically modified mice[J]. Circ Res, 2003,93 (10) : 907-916.
6Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure a randomized controlled trial [J]. JAMA,2002,287(12) : 1531-1540.
7Kawakami R, Saito Y, Kishimoto I, et al. Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction [J]. Circulation, 2004, 110 (21) : 3306- 3312.
